These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Invasive zygomycosis in patients treated for haematological malignancies]. Verweij PE; van der Velden WJ; Donnelly JP; Blijlevens NM; Warris A Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2597-602. PubMed ID: 18161258 [TBL] [Abstract][Full Text] [Related]
9. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation. Leithauser M; Kahl C; Aepinus C; Prall F; Maruschke M; Riemer H; Wolff D; Jost K; Hilgendorf I; Freund M; Junghanss C Transpl Infect Dis; 2010 Jun; 12(3):251-7. PubMed ID: 20002357 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Vazquez L; Mateos JJ; Sanz-Rodriguez C; Perez E; Caballero D; San Miguel JF Haematologica; 2005 Dec; 90(12 Suppl):ECR39. PubMed ID: 16464754 [TBL] [Abstract][Full Text] [Related]
19. Remission of universal vitiligo after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome. Zhai Y; Wang Q; Li Y; Liu L; Zhou H; Fu C; Miao M; Wu D; Jin S Ann Hematol; 2023 Jan; 102(1):209-210. PubMed ID: 36376597 [No Abstract] [Full Text] [Related]
20. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older. Mukherjee S Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911 [No Abstract] [Full Text] [Related] [Next] [New Search]